Pemigatinib is an oral med for treating cholangiocarcinoma, mainly for cases with FGFR2 fusions. The way it works is by blocking the FGFR signaling, which helps to manage the disease. You’ve got three dose options: 4.5 mg, 9 mg, and the highest one, 13.5 mg.
The go-to dose is 13.5 mg, and you take it every day for 14 days in every 21-day chunk. A bottle of pemigatinib holds 14 tablets, making it easy to follow the schedule.
Reviews
There are no reviews yet.